- Home
- LSEA vs ETON Comparison
LSEA vs ETON Comparison
Compare LSEA & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSEA
- ETON
- Stock Information
- Founded
- LSEA 2013
- ETON 2017
- Country
- LSEA United States
- ETON United States
- Employees
- LSEA N/A
- ETON N/A
- Industry
- LSEA Homebuilding
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- LSEA Consumer Discretionary
- ETON Health Care
- Exchange
- LSEA Nasdaq
- ETON Nasdaq
- Market Cap
- LSEA 222.1M
- ETON 428.5M
- IPO Year
- LSEA N/A
- ETON 2018
- Fundamental
- Price
- LSEA $6.10
- ETON $17.33
- Analyst Decision
- LSEA Buy
- ETON Strong Buy
- Analyst Count
- LSEA 4
- ETON 3
- Target Price
- LSEA $13.50
- ETON $27.67
- AVG Volume (30 Days)
- LSEA 200.4K
- ETON 221.4K
- Earning Date
- LSEA 05-12-2025
- ETON 05-13-2025
- Dividend Yield
- LSEA N/A
- ETON N/A
- EPS Growth
- LSEA N/A
- ETON N/A
- EPS
- LSEA 0.47
- ETON N/A
- Revenue
- LSEA $1,550,337,000.00
- ETON $39,011,000.00
- Revenue This Year
- LSEA N/A
- ETON $92.33
- Revenue Next Year
- LSEA $3.52
- ETON $52.62
- P/E Ratio
- LSEA $12.98
- ETON N/A
- Revenue Growth
- LSEA 28.13
- ETON 23.29
- 52 Week Low
- LSEA $5.41
- ETON $3.18
- 52 Week High
- LSEA $14.04
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- LSEA 48.21
- ETON 68.29
- Support Level
- LSEA $5.79
- ETON $16.43
- Resistance Level
- LSEA $6.25
- ETON $17.49
- Average True Range (ATR)
- LSEA 0.31
- ETON 0.88
- MACD
- LSEA 0.04
- ETON 0.19
- Stochastic Oscillator
- LSEA 43.02
- ETON 92.78
About LSEA Landsea Homes Corporation
Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.